BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6117464)

  • 1. The mechanism of action of virginiamycin M on the binding of aminoacyl-tRNA to ribosomes directed by elongation factor Tu.
    Chinali G; Moureau P; Cocito CG
    Eur J Biochem; 1981 Sep; 118(3):577-83. PubMed ID: 6117464
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Nov; 951(1):42-52. PubMed ID: 3142522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GTPase activity of elongation factor Tu and the 3'-terminal end of aminoacyl-tRNA.
    Parlato G; Guesnet J; Crechet JB; Parmeggiani A
    FEBS Lett; 1981 Mar; 125(2):257-60. PubMed ID: 6112171
    [No Abstract]   [Full Text] [Related]  

  • 4. Substitution of Val20 by Gly in elongation factor Tu. Effects on the interaction with elongation factors Ts, aminoacyl-tRNA and ribosomes.
    Jacquet E; Parmeggiani A
    Eur J Biochem; 1989 Nov; 185(2):341-6. PubMed ID: 2684669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of virginiamycin M on the stability of different ribosomal complexes to ultracentrifugation.
    Chinali G; Vanlinden F; Cocito C
    Biochim Biophys Acta; 1988 May; 950(1):67-74. PubMed ID: 3129013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a model for the interaction between elongation factor Tu and the ribosome.
    Weijland A; Parmeggiani A
    Science; 1993 Feb; 259(5099):1311-4. PubMed ID: 8446899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thiostrepton and 3'-terminal fragments of aminoacyl-tRNA on EF-Tu and ribosome-dependent GTP hydrolysis.
    Bhuta P; Chládek S
    Biochim Biophys Acta; 1982 Aug; 698(2):167-72. PubMed ID: 6127109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action of virginiamycin M on the acceptor, donor, and catalytic sites of peptidyltransferase.
    Chinali G; Moureau P; Cocito CG
    J Biol Chem; 1984 Aug; 259(15):9563-8. PubMed ID: 6430902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the 2' and 3' isomers of aminoacyl transfer ribonucleic acid in the in vitro peptide elongation on Escherichia coli ribosomes.
    Wagner T; Cramer F; Sprinzl M
    Biochemistry; 1982 Mar; 21(7):1521-9. PubMed ID: 7044415
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular mimicry in protein synthesis?
    Moore PB
    Science; 1995 Dec; 270(5241):1453-4. PubMed ID: 7491488
    [No Abstract]   [Full Text] [Related]  

  • 11. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
    Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
    EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antibiotics, N-acetylaminoacyl-tRNA and other agents on the elongation-factor-Tu dependent and ribosome-dependent GTP hydrolysis promoted by 2'(3')-O-L-phenylalanyladenosine.
    Campuzano S; Modolell J
    Eur J Biochem; 1981 Jun; 117(1):27-31. PubMed ID: 6114863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulvomycin, an inhibitor of protein biosynthesis preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA.
    Wolf H; Assmann D; Fischer E
    Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5324-8. PubMed ID: 364475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G222D mutation in elongation factor Tu inhibits the codon-induced conformational changes leading to GTPase activation on the ribosome.
    Vorstenbosch E; Pape T; Rodnina MV; Kraal B; Wintermeyer W
    EMBO J; 1996 Dec; 15(23):6766-74. PubMed ID: 8978702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibiotics kirromycin and pulvomycin bind to different sites on the elongation factor Tu from Escherichia coli.
    Pingoud A; Block W; Urbanke C; Wolf H
    Eur J Biochem; 1982 Apr; 123(2):261-5. PubMed ID: 6122571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action of the new antibiotic kirromycin].
    Sander G
    Reprod Nutr Dev (1980); 1981; 21(2):185-92. PubMed ID: 6130579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to epitopes in both C-terminal and N-terminal domains of Escherichia coli ribosomal protein L7/L12 inhibit elongation factor binding but not peptidyl transferase activity.
    Nag B; Tewari DS; Traut RR
    Biochemistry; 1987 Jan; 26(2):461-5. PubMed ID: 2435318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. tRNA and the guanosinetriphosphatase activity of elongation factor Tu.
    Swart GW; Parmeggiani A
    Biochemistry; 1989 Jan; 28(1):327-32. PubMed ID: 2539860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of kirromycin-like antibiotics.
    Parmeggiani A; Swart GW
    Annu Rev Microbiol; 1985; 39():557-77. PubMed ID: 3904612
    [No Abstract]   [Full Text] [Related]  

  • 20. Tet(M)-promoted release of tetracycline from ribosomes is GTP dependent.
    Burdett V
    J Bacteriol; 1996 Jun; 178(11):3246-51. PubMed ID: 8655505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.